Cost-Effectiveness Analysis of Asciminib in Patients With Chronic Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors in Colombia
Cost-Effectiveness Analysis of Asciminib in Patients With Chronic Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors in Colombia. // Value in Health Regional Issues. – URL: https://www.sciencedirect.com/science/article/pii/S2212109926001068?dgcid=rss_sd_all
Cost-Effectiveness Analysis of Asciminib in Patients With Chronic Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors in Colombia. Value in Health Regional Issues. https://www.sciencedirect.com/science/article/pii/S2212109926001068?dgcid=rss_sd_all
“Cost-Effectiveness Analysis of Asciminib in Patients With Chronic Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors in Colombia.” Value in Health Regional Issues.
@article{article70875,
title = {Cost-Effectiveness Analysis of Asciminib in Patients With Chronic Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors in Colombia},
journal = {Value in Health Regional Issues},
url = {https://www.sciencedirect.com/science/article/pii/S2212109926001068?dgcid=rss_sd_all}
}